DNLI
Denali Therapeutics Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -7.7% ·
aandelenstroom -0.9% ·
netto nieuwe posities -8.3%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +6 | 103.66M | $2.65B | +11 | −4 |
| Q1 2026 | 93 | +4 | 96.77M | $1.85B | +11 | −8 |
| Q4 2025 | 89 | 0 | 110.68M | $1.83B | +1 | — |
| Q3 2025 | 19 | 0 | 67.26M | $976.61M | — | −1 |
| Q2 2025 | 17 | +1 | 74.76M | $1.05B | +2 | −1 |
| Q1 2025 | 13 | +1 | 44.98M | $611.55M | +2 | −1 |
| Q4 2024 | 12 | -1 | 38.31M | $780.78M | — | −1 |
| Q3 2024 | 12 | 0 | 34.10M | $993.27M | +1 | −1 |
| Q2 2024 | 12 | — | 35.56M | $825.78M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 12.31M | -7.7% | $250.96M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 12.31M | -7.7% | $250.96M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 12.31M | -7.7% | $250.96M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 12.31M | -7.7% | $250.96M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 9.85M | -8.2% | $200.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 9.85M | -8.2% | $200.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 9.85M | -8.2% | $200.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 9.85M | -8.2% | $200.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 9.85M | -8.2% | $200.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 9.85M | -8.2% | $200.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 9.85M | -8.2% | $200.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (passief) | 4.54M | — | $92.63M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 3.06M | +6.6% | $62.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 3.06M | +6.6% | $62.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 2.94M | -0.7% | $59.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passief) | 2.94M | -0.7% | $59.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 1.79M | -9.1% | $36.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Norges Bank ✦ (passief) | 1.07M | +168.1% | $21.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 829.91K | +6.8% | $16.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 829.91K | +6.8% | $16.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 792.50K | +44.8% | $16.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Point72 Asset Management ✦ | 548.74K | +64.5% | $11.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Millennium Management ✦ | 404.22K | +571.8% | $8.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 179.88K | +80.8% | $3.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| AQR Capital Management | $466,605 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 265 houders, 147.10M aandelen, $2.60B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.86K aand · $71,625
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie